Di Nuzzo Private Wealth, Inc. Haemonetics Corp Transaction History
Di Nuzzo Private Wealth, Inc.
- $618 Million
- Q4 2024
A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Haemonetics Corp stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 10 shares of HAE stock, worth $631. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10
Previous 7
42.86%
Holding current value
$631
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding HAE
# of Institutions
347Shares Held
51.8MCall Options Held
600KPut Options Held
474K-
Black Rock Inc. New York, NY5.96MShares$377 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.18MShares$327 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.42MShares$279 Million0.29% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.24MShares$268 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.55MShares$161 Million0.12% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.24B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...